MS Flashcards


Set Details Share
created 1 year ago by abedfordpowell
6 views
show moreless
Page to share:
Embed this setcancel
COPY
code changes based on your size selection
Size:
X
Show:

1

What are the two treatments for MS exacerbations

1. CCS

2. ACTH

2

What is the 1st line CCS

methylprednisolone

3

Sleep disturbances, metallic taste (PO), GI upset, and hyperglycemia are short term side effects of what class of drugs

CCS

4

What is the only FDA approved treatment for MS exacerbations

ACTH $

5

first generation disease modifying therapies for MS:

4 interferon produces

Glatiramer acetate

6

4 IFN products:

1. Avonex

2. Rebif

3. Betaseron/Extavia

4. Plegridy

7

What is the dosing for Avonex

6 million units IM weekly

8

What is the dosing for Rebif

22 mcg SQ three times weekly given at least 48 hours apart

9

What is the dosing for Betaseron/Extavia

8 million units SQ every other day

10

What is the dosing for Plegridy

6.3 mcg SQ every 14 days

11

Which two IFN products are high potency

Rebif

Betaseron/Extavia

12

Which IFN produce has more injection site reactions

Betaseron/Extavia

13

Pre-medication with antipyretics can be useful with which agent

Plegridy

14

4 ADRs of IFN therapy

1. Psychiatric issues

2. Flu-like symptoms

3. Injection site reactions

4. Increased LFTs

15

IFN therapies should be refrigerated up until administration?

False

Let sit at room temperature and do not expel air bubble in profiled syringes

16

Risk of Creutzfeldt-Jakob disease transmission is increased with IFN therapy with formulations containing albumin?

True

17

What is the preferred agent in pregnancy?

Copaxone/Glatopa

18

Copaxone/Glatopa dosing:

20 mg SQ three times a week

19

All 1st generation medications may not show efficacy until 1-2 years after starting?

True

20

ADRs of glatiramer acetate

Chest pain

Diaphoresis

Dyspnea

Flushing

Injection site reactions

21

All sphingosine-1-phosphate receptor modulators are CI in what conditions

1. MI

2. Unstable angine

3. Stroke/TIA

4. Class III/IV or hospitalization for HF in the last 6 months

22

4 sphingosine-1-phosphate receptor modulators

1. Gilenya

2. Zeposia

3. Ponvory

4. Mayzent

23

Relapsing forms of MS are treated with

sphingosine-1-phosphate receptor modulators

24

Gilenya

Fingolimod

25

Zeposia

Ozanimod

26

Ponvory

Ponesimod

27

Mayzent

Siponimod

28

All sphingosine-1-phosphate receptor modulators are given by what route`

Oral

29

what should be screened for for all sphingosine-1-phosphate receptor modulators

Latent infections

30

What sphingosine-1-phosphate receptor modulator is CI in severe untreated sleep apnea and concomitant use of MAOI

Zeposia

31

What sphingosine-1-phosphate receptor modulator is CI in CYP2C9*3/*3 genotype

Mayzent

32

What sphingosine-1-phosphate receptor modulator is CI with class Ia and III anti arrhythmic agents

Gilenya- QTc prolongation

33

Gilenya has what risk?

PML

34

Patients must be monitored for 6 hours post dose for what two sphingosine-1-phosphate receptor modulators

Gilenya

Mayzent

35

ADRs of sphingosine-1-phosphate receptor modulators

Bradycardia/bradyarrhythmias- ECGs

Macular edema- Eye exams

Fetal risk

Hepatotoxicity- LFTs

36

Nuclear factor-like-2-activators

Tecfidera (dimethyl fumigate)

Vumerity (Diroximel fumigate)

Bafiertam (monomethyl fumurate)

37

All nuclear factor-like-2-activators are given by what route

Oral

38

Nuclear factor-like-2-activators can be crushed, chewed, and sprinkled on food for patients who are not good at swallowing medications?

False

39

Main ADR of Nuclear factor-like-2-activators

Flushing

40

How to treat flushing associated with Nuclear factor-like-2-activators?

Take aspirin 30 minutes before and administer with food

41

Brand name of teriflunomide

Aubagio

42

CI of Aubagio

Pregnancy or not using adequate protection

43

Cholestyramine can be used for accelerated elimination of what medication?

Aubagio

44

ADRs of Aubagio

Alopecia

N/D

Lymphocytopenia

Infection risk

45

What are the two monoclonal antibodies

Tysabri (Natalizumab)

Kesimpta (Ofatumumab)

46

Which moAb binds to the alpha-4 subunit of intern on lymphocytes

Tysabri

47

Dosing of Tysabri

300 mg IV over 1 hr q 4 weeks

48

Which moAb is an anti-CD20

Kesimpta

Ocrevus

Briumvi

49

Dosing of Kesimpta

20 mg SQ once weekly for 3 doses then once monthly starting at week 4

50

Which drug is under the REMS program for PML?

Tysabri

51

Which agent can be initial first line therapy in severe RRMS

Tysabri

52

Which agent has a CI for active HepB infection

Kesimpta

53

What agent should be screened for John Cunningham virus?

Tysabri

54

Which agent is the only agent that has an indication for PPMS?

Ocrevus

55

Which moAbs are given IV

Tysabri

Lemtrada

Ocrevus

Briumvi

56

Which agent has a REMS program for autoimmunity, infusion reactions, and malignancies

Lemtrada

57

Pre-medications with steroids +/- antipyretics and ppx with acyclovir would be beneficial with which moAb?

Lemtrada

58

Pre-medication with methylprednisolone IV and antihistamine 30-60 minutes before infusion +/- APAP

Ocrevus

59

Pre-medication with methylprednisolone IV and antihistamine and considering an antipyretic would be beneficial with which moAb?

Briumvi

60

All vaccinations should be completed how long before treatment

6 weeks

61

ADRs of Alemtuzumab (Lemtrada)

Rash

Thyroid disease

Lymphocytopenia

Antibody development

62

What is only oral anti-neoplastic agent?

Mavenclad (cladribin)

63

Mavenclad can be used to treat

RRMS and SPMS

64

What agent has a boxed warning for malignancies and teratogenicity requiring 6 months of contraception?

Mavenclad

65

CI of Mavenclad

Malignancy, HIV, or active chronic infections